Ingredients Purified Water, L-Carnitine Base, Acidity Regulator (Citric Acid), Guarana Seed Extract, Taurine, Flavouring, Preservatives (Potassium Sorbate, Sodium Benzoate), Sweeteners (Sodium saccharin, Acesulfame K)
FOXO4-DRI Potential Selectivity As mentioned, FOXO4-DRI is believed to selectively disrupt the binding of FOXO4 to p53, which may lead to the activation of p53, which in turn may stimulate the process of removing senescent cells
HGH Fragment 176-191 has no human trial data and relies entirely on animal studies and extrapolation from AOD-9604's human data
However, checking with your insurance provider before submitting any new treatments is important
Origin BPC-157 originates from a protective protein sequence associated with gastric tissue
Adjusting protocols based on progress requires thoughtful interpretation of available data